[1] Camilleri M.Leaky gut: mechanisms, measurement and clinical implications in humans[J]. Gut, 2019, 68(8):1516-1526. [2] Baumgart DC, Dignass AU.Intestinal barrier function[J]. Curr Opin Clin Nutr Metab Care, 2002, 5(6):685-694. [3] Ren Z, Guo C, Yu S, et al.Progress in Mycotoxins Affecting Intestinal Mucosal Barrier Function[J]. Int J Mol Sci, 2019, 20(11):2777. [4] Yi D, Hou Y, Wang L, et al.L-Glutamine enhances enterocyte growth via activation of the mTOR signaling pathway independently of AMPK[J]. Amino Acids, 2015, 47(1): 65-78. [5] Zou XP, Chen M, Wei W, et al.Effects of enteral immunonutrition on the maintenance of gut barrier function and immune function in pigs with severe acute pancreatitis[J]. JPEN J Parenter Enteral Nutr, 2010, 34(5): 554-566. [6] Zhang X, Jiang X.Effects of enteral nutrition on the barrier function of the intestinal mucosa and dopamine receptor expression in rats with traumatic brain injury[J]. JPEN J Parenter Enteral Nutr, 2015, 39(1):114-123. [7] Santos RG, Quirino IE, Viana ML, et al.Effects of nitric oxide synthase inhibition on glutamine action in a bacterial translocation model[J]. Br J Nutr 2014, 111(1):93-100. [8] Li Y, Chen Y, Zhang J, et al.Protective effect of glutamine-enriched early enteral nutrition on intestinal mucosal barrier injury after liver transplantation in rats[J]. Am J Surg, 2010, 199(1):35-42. [9] Hou YC, Chu CC, Ko TL, et al.Effects of alanyl-glutamine dipeptide on the expression of colon-inflammatory mediators during the recovery phase of colitis induced by dextran sulfate sodium[J]. Eur J Nutr, 2013; 52(3):1089-1098. [10] Mondello S, Galuppo M, Mazzon E, et al.Glutamine treatment attenuates the development of ischaemia/reperfusion injury of the gut[J]. Eur J Pharmacol, 2010, 643(2-3):304-315. [11] Bertrand J, Goichon A, De' chelotte P, Co¨ effier M. Regulation of intestinal protein metabolism by amino acids[J]. Amino Acids, 2013, 45(3):443-450. [12] Beutheu S, Ouelaa W, Guerin C, et al.Glutamine supplementation, but not combined glutamine and arginine supplementation, improves gut barrier function during chemotherapy-induced intestinal mucositis in rats[J]. Clin Nutr, 2014, 33(4):694-701. [13] Wang B, Wu Z, Ji Y, et al.L-Glutamine enhances tight junction integrity by activating CaMK kinase 2-AMP-activated protein kinase signaling in intestinal porcine epithelial cells[J]. J Nutr, 2016, 146(3):501-508. [14] Ghouzali I, Lemaitre C, Bahlouli W, et al.Targeting immunoproteasome and glutamine supplementation prevent intestinal hyperpermeability[J]. Biochim Biophys Acta Gen Subj, 2017, 1861(1 Pt A):3278-3288. [15] Noth R, Häsler R, Stüber E, et al.Oral glutamine supplementation improves intestinal permeability dysfunction in a murine acute graftvs.-host disease model[J]. Am J Physiol Gastrointest Liver Physiol, 2013, 304: G646-G654. [16] Dai ZL, Li XL, Xi PB, et al.L-Glutamine regulates amino acid utilization by intestinal bacteria[J]. Amino Acids, 2013, 45(3): 501-512. [17] Ren W, Duan J, Yin J, et al.Dietary L-glutamine supplementation modulates microbial community and activates innate immunity in the mouse intestine[J]. Amino Acids, 2014, 46(10): 2403-2413. [18] de Souza AZ, Zambom AZ, Abboud KY, et al. Oral supplementation with Lglutamine alters gut microbiota of obese and overweight adults: a pilot study[J]. Nutrition, 2015, 31(6): 884-889. [19] Wang A, Keita AV, Phan V, et al.Targeting mitochondria-derived reactive oxygen species to reduce epithelial barrier dysfunction and colitis[J]. Am J Pathol, 2014, 184(9):2516-2527. [20] Coeffier M, Marion-Letellier R, Dechelotte P.Potential for amino acids supplementation during inflammatory bowel diseases[J]. Inflamm Bowel Dis, 2010, 16(3):518-524. [21] Bertrand J, Marion-Letellier R, Azhar S, et al.Glutamine enema regulates colonic ubiquitinated-proteins but not proteasome activities during TNBSinduced colitis leading to increased mitochondrial activity[J]. Proteomics, 2015, 15(13):2198-2210. [22] Leite RD, Lima NL, Leite CA, et al.Improvement of intestinal permeability with alanyl-glutamine in HIV patients: a randomized, double blinded, placebocontrolled clinical trial[J]. Arq Gastroenterol, 2013, 50(1): 56-63. [23] Bertiaux-Vandaёle N, Youmba SB, Belmonte L, et al.The expression and the cellular distribution of the tight junction proteins are altered in irritable bowel syndrome patients with differences according to the disease subtype[J]. Am J Gastroenterol, 2011, 106(12): 2165-2173. [24] Zhou Q, Costinean S, Croce CM, et al. MicroRNA 29 targets nuclear factorkappaB-repressing factor and Claudin 1 to increase intestinal permeability [J]. Gastroenterology, 2015, 148(1): 158-169.e8. [25] Zhou Q, Souba WW, Croce CM, Verne GN.MicroRNA-29a regulates intestinal membrane permeability in patients with irritable bowel syndrome[J]. Gut, 2010, 59(6): 775-784. [26] Bertrand J, Ghouzali I, Guérin C, et al.Glutamine restores tight junction protein claudin-1 expression in colonic mucosa of patients with diarrhea-predominant irritable bowel syndrome[J]. JPEN J Parenter Enteral Nutr, 2016, 40(8): 1170-1176. [27] Benjamin J, Makharia G, Ahuja V, et al.Glutamine and whey protein improve intestinal permeability and morphology in patients with Crohn’s disease: a randomized controlled trial[J]. Dig Dis Sci, 2012, 57(4): 1000-1012. [28] Akobeng AK, Elawad M, Gordon M. Glutamine for induction of remission in Crohn’s disease [J]. Cochrane Database Syst Rev, 2016, 2:CD007348. [29] Anderson PM, Lalla RV.Glutamine for Amelioration of Radiation and Chemotherapy Associated Mucositis during Cancer Therapy[J]. Nutrients, 2020, 12(6): 1675. [30] Filho JC, Bergström J, Stehle P, Fürst P.Simultaneous measurements of free amino acid patterns ofplasma, muscle and erythrocytes in healthy human subjects[J]. Clin Nutr, 1997, 16(6): 299-305. [31] Souba WW, Klimberg VS, Plumley DA, et al.The role of glutamine in maintaining a healthy gut and supporting the metabolic response to injury and infection[J]. J Surg Res, 1990, 48(4): 383-391. [32] Yarom N, Hovan A, Bossi P, et al.Systematic review of natural and miscellaneous agents for the management of oral mucositis in cancer patients and clinical practice guidelines-part 1: Vitamins, minerals, and nutritional supplements[J]. Support Care Cancer, 2019, 27(10): 3997-4010. [33] Labow BI, Souba WW.Glutamine[J]. World J Surg, 2000, 24(12): 1503-1513. [34] Cockerham MB, Weinberger BB, Lerchie SB.Oral glutamine for the prevention of oral mucositis associated with high-dose paclitaxel and melphalan for autologous bone marrow transplantation[J]. Ann Pharmacother,2000, 34(3): 300-303. [35] Schloerb PR, Skikne BS.Oral and parenteral glutamine in bone marrow transplantation: a randomized, double-blind study[J]. JPEN J Parenter Enteral Nutr, 1999, 23(3): 117-122. [36] Peterson DE, Jones JB, Petit RG 2nd. Randomized, placebo-controlled trial of Saforis for prevention and treatment of oral mucositis in breast cancer patients receiving anthracycline-based chemotherapy[J]. Cancer, 2007, 109(2): 322-331. [37] Pytlík R, Benes P, Patorková M, et al.Standardized parenteral alanyl-glutamine dipeptide supplementation is not beneficial in autologous transplant patients: a randomized, double-blind, placebo controlled study[J]. Bone Marrow Transplant, 2002, 30(12):953-961. [38] Anderson PM.Supportive care after chemotherapy and radiation with a swish and swallow glutamine+disaccharide nutritional supplement to reduce mucositis and improve enteral nutrition[C]. In Proceedings of the 46th Congress of The International Society of Paediatric Oncology (SIOP), Toronto, ON, Canada, October 2014. [39] Kaufmann Y, Klimberg VS.Effect of glutamine on gut glutathione fractional release in the implanted tumor model[J]. Nutr Cancer, 2007, 59(2): 199-206. |